Protein Kinase C-epsilon, antagonists & inhibitors
- Name
- Protein Kinase C-epsilon, antagonists & inhibitors
- Accession Number
- DBCAT005208
- Description
Not Available
- Drugs
Drug Drug Description KAI-1678 KAI-1678 is under investigation in clinical trial NCT01106716 (Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia). - Drugs & Drug Targets
Drug Target Type